Skip to main content

Advertisement

Log in

The association between chronic osteomyelitis and increased risk of diabetes mellitus: a population-based cohort study

  • Article
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

Abstract

Chronic inflammation is a well-known risk factor for type 2 diabetes mellitus (T2DM). The influence of chronic osteomyelitis (COM), an inflammatory disease, on the risk of developing T2DM remains unknown. This study investigated the risk of developing T2DM among COM patients. Using a retrospective cohort study, we identified 20,641 patients with COM and 82,564 age- and sex-matched controls for comparison from the Taiwan National Health Insurance Database (NHIRD) from 1997 to 2010. We followed up the COM cohort and the comparison cohort to compare the incidences of diabetes (ICD-9-CM code 250) until the end of 2010 or until the patients were censored because of death or withdrawal from the insurance program. The diabetes risk was analyzed using the Cox proportional hazards regression model. The incidence of T2DM was 1.6-fold higher in the group of COM patients than in the comparison group (29.1 vs. 18.2 per 10,000 person-years). The COM patients exhibited a higher diabetes risk [adjusted hazard ratio (aHR) = 1.64, 95 % confidence interval (CI) = 1.44–1.87] after controlling for the baseline and comorbidities. Younger and higher income patients exhibited a higher COM-to-reference incidence rate ratio (IRR) for T2DM compared with that of their counterparts. We also observed an increased risk of T2DM in COM patients with comorbidities (aHR = 1.70, 95 % CI = 1.47–1.96) compared with that of their non-COM counterparts. This is the first study to report the association between COM and an increased risk of developing T2DM, particularly among younger and higher income patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Nolan CJ, Damm P, Prentki M (2011) Type 2 diabetes across generations: from pathophysiology to prevention and management. Lancet 378:169–181

    Article  PubMed  Google Scholar 

  2. Crandall JP, Knowler WC, Kahn SE et al (2008) The prevention of type 2 diabetes. Nat Clin Pract Endocrinol Metab 4:382–393

    Article  PubMed Central  PubMed  Google Scholar 

  3. Chan JC, Malik V, Jia W et al (2009) Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 301:2129–2140

    Article  CAS  PubMed  Google Scholar 

  4. Misra A, Khurana L (2008) Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metab 93(11 Suppl 1):S9–S30

    Article  CAS  PubMed  Google Scholar 

  5. Liu KH, Chan YL, Chan WB et al (2006) Mesenteric fat thickness is an independent determinant of metabolic syndrome and identifies subjects with increased carotid intima-media thickness. Diabetes Care 29:379–384

    Article  PubMed  Google Scholar 

  6. Diabetes Genetics Initiative of Broad Institute of Harvard and MIT, Lund University, and Novartis Institutes of BioMedical Research et al (2007) Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316:1331–1336

    Article  Google Scholar 

  7. Pinney SE, Simmons RA (2010) Epigenetic mechanisms in the development of type 2 diabetes. Trends Endocrinol Metab 21:223–229

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. Malik VS, Popkin BM, Bray GA et al (2010) Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis. Diabetes Care 33:2477–2483

    Article  PubMed Central  PubMed  Google Scholar 

  9. Popkin BM, Horton S, Kim S et al (2001) Trends in diet, nutritional status, and diet-related noncommunicable diseases in China and India: the economic costs of the nutrition transition. Nutr Rev 59:379–390

    Article  CAS  PubMed  Google Scholar 

  10. Guilherme A, Virbasius JV, Puri V et al (2008) Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 9:367–377

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  11. Ide R, Hoshuyama T, Wilson D et al (2011) Periodontal disease and incident diabetes: a seven-year study. J Dent Res 90:41–46

    Article  CAS  PubMed  Google Scholar 

  12. Basaranoglu M, Basaranoglu G (2011) Pathophysiology of insulin resistance and steatosis in patients with chronic viral hepatitis. World J Gastroenterol 17:4055–4062

    Article  PubMed Central  PubMed  Google Scholar 

  13. Hatzenbuehler J, Pulling TJ (2011) Diagnosis and management of osteomyelitis. Am Fam Physician 84:1027–1033

    PubMed  Google Scholar 

  14. Game F (2010) Management of osteomyelitis of the foot in diabetes mellitus. Nat Rev Endocrinol 6:43–47

    PubMed  Google Scholar 

  15. Berendt AR, Peters EJ, Bakker K et al (2008) Diabetic foot osteomyelitis: a progress report on diagnosis and a systematic review of treatment. Diabetes Metab Res Rev 24(Suppl 1):S145–S161

    PubMed  Google Scholar 

  16. Senneville E, Lombart A, Beltrand E et al (2008) Outcome of diabetic foot osteomyelitis treated nonsurgically: a retrospective cohort study. Diabetes Care 31:637–642

    Article  PubMed  Google Scholar 

  17. Kreng VB, Yang CT (2011) The equality of resource allocation in health care under the National Health Insurance System in Taiwan. Health Policy 100:203–210

    Article  PubMed  Google Scholar 

  18. Chung WS, Peng CL, Lin CL et al (2013) Rheumatoid arthritis increases the risk of deep vein thrombosis and pulmonary thromboembolism: a nationwide cohort study. Ann Rheum Dis. doi:10.1136/annrheumdis-2013-203380

    PubMed Central  Google Scholar 

  19. Chung WS, Lin CL, Ho FM et al (2014) Asthma increases pulmonary thromboembolism risk: a nationwide population cohort study. Eur Respir J 43:801–807

    Article  PubMed  Google Scholar 

  20. Cheng CL, Kao YH, Lin SJ et al (2011) Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf 20:236–242

    Article  PubMed  Google Scholar 

  21. Hotamisligil GS (2006) Inflammation and metabolic disorders. Nature 444:860–867

    Article  CAS  PubMed  Google Scholar 

  22. Medzhitov R, Janeway C Jr (2000) Innate immunity. N Engl J Med 343:338–344

    Article  CAS  PubMed  Google Scholar 

  23. Fullilove S, Jellis J, Hughes SP et al (2000) Local and systemic concentrations of tumour necrosis factor-alpha, interleukin-6 and interleukin-8 in bacterial osteomyelitis. Trans R Soc Trop Med Hyg 94:221–224

    Article  CAS  PubMed  Google Scholar 

  24. Biffl WL, Moore EE, Moore FA et al (1996) Interleukin-6 delays neutrophil apoptosis via a mechanism involving platelet-activating factor. J Trauma 40:575–578

    Article  CAS  PubMed  Google Scholar 

  25. Gonzalez BE, Teruya J, Mahoney DH Jr et al (2006) Venous thrombosis associated with staphylococcal osteomyelitis in children. Pediatrics 117:1673–1679

    Article  PubMed  Google Scholar 

  26. Helmrich SP, Ragland DR, Leung RW et al (1991) Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. N Engl J Med 325:147–152

    Article  CAS  PubMed  Google Scholar 

  27. Tsezou A, Poultsides L, Kostopoulou F et al (2008) Influence of interleukin 1alpha (IL-1alpha), IL-4, and IL-6 polymorphisms on genetic susceptibility to chronic osteomyelitis. Clin Vaccine Immunol 15:1888–1890

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  28. Kubaszek A, Pihlajamäki J, Komarovski V et al (2003) Promoter polymorphisms of the TNF-alpha (G-308A) and IL-6 (C-174G) genes predict the conversion from impaired glucose tolerance to type 2 diabetes: the Finnish Diabetes Prevention Study. Diabetes 52:1872–1876

    Article  CAS  PubMed  Google Scholar 

  29. Rabi DM, Edwards AL, Southern DA et al (2006) Association of socio-economic status with diabetes prevalence and utilization of diabetes care services. BMC Health Serv Res 6:124

    Article  PubMed Central  PubMed  Google Scholar 

  30. Robbins JM, Vaccarino V, Zhang H et al (2001) Socioeconomic status and type 2 diabetes in African American and non-Hispanic white women and men: evidence from the Third National Health and Nutrition Examination Survey. Am J Public Health 91:76–83

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  31. Agardh E, Allebeck P, Hallqvist J et al (2011) Type 2 diabetes incidence and socio-economic position: a systematic review and meta-analysis. Int J Epidemiol 40:804–818

    Article  PubMed  Google Scholar 

  32. McEwen BS, Gianaros PJ (2010) Central role of the brain in stress and adaptation: links to socioeconomic status, health, and disease. Ann N Y Acad Sci 1186:190–222

    Article  PubMed Central  PubMed  Google Scholar 

  33. Adler NE, Boyce T, Chesney MA et al (1994) Socioeconomic status and health. The challenge of the gradient. Am Psychol 49:15–24

    Article  CAS  PubMed  Google Scholar 

  34. Chung HY, Cesari M, Anton S et al (2009) Molecular inflammation: underpinnings of aging and age-related diseases. Ageing Res Rev 8:18–30

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  35. Chung HY, Sung B, Jung KJ et al (2006) The molecular inflammatory process in aging. Antioxid Redox Signal 8:572–581

    Article  CAS  PubMed  Google Scholar 

  36. Vasto S, Candore G, Balistreri CR et al (2007) Inflammatory networks in ageing, age-related diseases and longevity. Mech Ageing Dev 128:83–91

    Article  CAS  PubMed  Google Scholar 

  37. Lorenzo C, Okoloise M, Williams K et al (2003) The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Diabetes Care 26:3153–3159

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by study projects in China Medical University (CMU102-BC-2) the Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (DOH102-TD-B-111-004), the Taiwan Ministry of Health and Welfare Cancer Research Center for Excellence (MOHW103-TD-B-111-03), and the International Research-Intensive Centers of Excellence in Taiwan (NSC101-2911-I-002-303). The funders had no role in the study design, data collection and analysis, decision to publish, or manuscript preparation. No additional external funding was received for this study. All authors state that they have no conflicts of interest.

Author contributions

All the authors have contributed substantially and are in agreement on the manuscript content. Conception/design: Shih-Yi Lin, Yen-Jung Chang, Chia-Hung Kao. Provision of study materials: Chia-Hung Kao. Collection and/or assembly of data: all authors. Data analysis and interpretation: Shih-Yi Lin, Cheng-Li Lin, Yen-Jung Chang, Chia-Hung Kao. Manuscript writing: all authors. Final approval of manuscript: all authors.

Conflict of interest

All authors report no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C.-H. Kao.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lin, SY., Lin, CL., Tseng, CH. et al. The association between chronic osteomyelitis and increased risk of diabetes mellitus: a population-based cohort study. Eur J Clin Microbiol Infect Dis 33, 1647–1652 (2014). https://doi.org/10.1007/s10096-014-2126-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-014-2126-7

Keywords

Navigation